Quality of Partnership in Patients with Erectile Dysfunction after Sildenafil Treatment

Objective: A comprehensive investigation on the quality of partnership of male patients with erectile dysfunction (ED) after treatment with sildenafil vs. untreated patients, as perceived by both the patients and their female partners. Methods: This report describes an observational, cross-sectional exploratory study comparing ED patients responsive to sildenafil with ED patients prior to therapy. Assessments included the ‘International lndex of Erectile Function’ (IIEF) and the ‘Partnerschaftsfragebogen’ (PFB), a partnership questionnaire used in German-speaking countries. The comparability of the two study groups was examined using a stepwise logit model. Significant intergroup differences regarding demographics and history were identified and included as confounding variables in the assessment of Quality of Partnership differences using ANCOVA. A regression analysis was performed to determine the association between the mean total IIEF scores and Quality of Partnership measures. Results: 105 patients were included in the study. After adjustment for confounding variables, the groups varied significantly with respect to Quality of Partnership as perceived by men (mean score PFB 61.8 ± 13.9 vs. 54.4 ± 15.5; p < 0.001) and women (mean score PFB 63.1 ± 13.6 vs. 57.0 ± 14.7; p = 0.006). In men, all three PFB subscales (quarreling, tenderness, togetherness) differed significantly between the two study groups. In the female partners, the tenderness and togetherness domains varied significantly. Erectile function correlated highly significantly with tenderness and togetherness in both the male patients and their partners. Conclusion: Our data indicate that the Quality of Partnership reported by both the men and their female partners is significantly better in appropriately treated ED patients than in untreated controls.

References

• 1 Althof S E, Turner L A, Levine S B, Bodner D, Kursh E D, Resnick M I. Through the eyes of women: the sexual and psychological responses of women to their partner's treatment with self-injection or external vacuum therapy.  J Urol. 1992;  147 1024-1027
• 2 Benkert O, Maier W, Holsboer F. Multiaxial classification of male sexual dysfunction.  Br J Psych. 1985;  146 628-632
• 3 Benkert O, Ruof J, Graf-Morgenstern M, Porst H, Müller M J. Lebensqualität und Partnerschaftsqualität bei Patienten mit erektiler Dysfunktion nach Sildenafil Therapie. Poster presented at the 52nd meeting of the German Urological Society Hamburg; 22. Sept. 2000
• 4 Carroll J L, Bagley D H. Evaluation of sexual satisfaction in partners of men experiencing erectile failure.  J Sex Marital Ther. 1990;  16 70-78
• 5 Denil J, Ohl D A, Smythe C. Vacuum erection device in spinal cord injured men: patient and partner satisfaction.  Arch Phys Med Rehabil. 1996;  77 750-753
• 6 Goecker D, Babinsky S, Beier K. Sexual relations with multiple sclerosis patients.  Sexuologie. 1998;  5 193-202
• 7 Goldstern I, Lue T F, Padma-Nathan H, Rosen R C, Steers W D, Wicker P A, for the Sildenafil study group. Oral Sildenafil in the treatment of erectile dysfunction.  N Engl J Med. 1998;  338 1397-1404
• 8 Hahlweg K. Fragebogen zur Partnerschaftsdiagnostik. Handanweisung. Hogrefe Verlag GmbH Göttingen; 1996
• 9 Hahlweg K. Partnership questionnaire PFB. In Hersen M, Bellack AS (eds.) Dictionary of behavioral assessment devices. New York; Pergamon: 1988: 337-339
• 10 Lüders M, Boxdorfer S, Beier K M. Partnership and sexuality in cases of Parkinson's disease.  Sexuologie. 1999;  6 18-29
• 11 McCabe M P. Intimacy and quality of life among sexually dysfunctional men and women.  J Sex Marital Ther. 1997;  23 276-290
• 12 Müller M J, Benkert O. Lower self-reported depressive symptoms in patients with erectile dysfunction after treatment with sildenafil. J Affect Disord; in press
• 13 NIH . Consensus Development Panel on Impotence.  Impotence. JAMA. 1993;  270 83-90
• 14 Rosen R C, Riley A, Wagner G, Osterloh I H, Kirkpatrick J, Mishra A. International index of erectile function (IIEF) : a multidimensional scale for assessment of erectile dysfunction.  Urology. 1997;  49 822-830
• 15 Spilker B, Revicki D A. Taxonomy of Quality of Life. In Spilker B, editor. Quality of Life and Pharmacoeconomics in Clinical Trials. 2nd edition. Philadelphia: Lippincott-Raven Publishers 1996: 25-31
• 16 Turner L A, Althof S E, Levine S B, Bodner D R, Kursh E D, Resnick M I. External vacuum devices in the treatment of erectile function: a one year study of sexual and psychosocial impact.  J Sex Marital Ther. 1991;  17 81-93
• 17 Williams G, Abbou C C, Amar E T, Desvaux P, Flam T A, Lycklama a Nijeholt G A, Lynch S F, Morgan R J, Muller S C, Porst H, Pryor J P, Ryan P, Witzsch U K F, Hall M M, Place V A, Spivack A P, Todd L K, Gesundheit N. The effect of transurethral alprostadil on the quality of life of men with erectile dysfunction and their partners.  Br J Urol. 1998;  82 847-854
• 18 Hulting C. Partner's perceptions of the efficacy of sildenafil citrate (VIAGRA) in the treatment of erectile dysfunction.  Int J Clin Pract. 1999;  Suppl 102 16-18